Skip to main content
Journal of Genetic Engineering and Biotechnology

Table 1 Demographic and biochemical data of the studied groups

From: Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma

 

Endometrial hyperplasia (n = 30)

Endometrial carcinoma (n = 30)

Control (n = 30)

Age (years)

49.73 ± 1.07

52.16 ± 1.08

51.83 ± 1.17

 p value

0.12*

0.79$

0.19!

Bodyweight (kg)

93.47 ± 2.71

77.67 ± 2.12

84.70 ± 2.58

 p value

< 0.001*

0.06$

0.02!

Estrogen (pg/mL)

30.87 ± 2.34

26.80 ± 1.75

29.67 ± 2.06

 p value

0.17*

0.33$

0.68!

Catalase (mU/mL)

0.18 ± 0.01

0.21 ± 0.02

0.17 ± 0.01

 p value

0.093*

0.027$

0.57!

Malondialdehyde (μmol/L)

6.51 ± 0.28

9.09 ± 0.36

3.17 ± 0.21

 p value

< 0.001*

< 0.001$

< 0.001!

  1. M ± SE: mean ± standard error; pairwise comparison between each 2 groups was done using post hoc test
  2. *Comparison between endometrial hyperplasia and endometrial carcinoma
  3. $Comparison between endometrial carcinoma and control
  4. !Comparison between control and endometrial hyperplasia
Back to article page